在该药上市后期间,已报道发生其他包括以硬结、蜂窝织炎、血肿、脓肿、无菌脓肿以及坏死为指征的注射部位反应事件。
In the postmarketing period, additional cases of injection site reaction with features including induration, cellulitis, hematoma, abscess, sterile abscess, and necrosis, have been reported.
在该药上市后期间,已报道发生其他包括以硬结、蜂窝织炎、血肿、脓肿、无菌脓肿以及坏死为指征的注射部位反应事件。
In the postmarketing period, additional cases of injection site reaction with features including induration, cellulitis, hematoma, abscess, sterile abscess, and necrosis, have been reported.
应用推荐